Material from, or relating to, the British Medical Journal [BMJ]

My response to this BMJ news article

Jacqui Wise states that a new ‘system allowing drugs to be approved in the UK by other “trusted” regulators such as the US Food and Drug Administration (FDA) is sparking … Continue reading My response to this BMJ news article

Undisclosed financial COI [US psychiatry]

This BMJ research is open access and can be read in full here.

Are antidepressants overprescribed? Yes.

Recently, Dr Des Spence submitted, after more than a decade, a follow up to his 2013 ‘Head to Head’ debate in the BMJ with Prof Ian C Reid [see here … Continue reading Are antidepressants overprescribed? Yes.

Drug industry payments to groups of influential MPs – “the next great parliamentary scandal?”

I have submitted  the following rapid response to the BMJ News article: Drug industry payments to groups of influential MPs – “the next great parliamentary scandal?” I am in agreement … Continue reading Drug industry payments to groups of influential MPs – “the next great parliamentary scandal?”

The potential and limits of scrutiny in medical research

I have submitted  the following rapid response to the BMJ Editorial: The potential and limits of scrutiny in medical research: Thank you editor for welcoming ideas on this important matter. … Continue reading The potential and limits of scrutiny in medical research

Déjà vu

The recent publication in JAMA Psychiatry: Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-Analysis made me feel that I had been here before. Once again, a … Continue reading Déjà vu